MedPath
FDA Approval

Dexamethasone Sodium Phosphate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 25, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Dexamethasone(10 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amneal Pharmaceuticals Private Limited

Amneal Pharmaceuticals LLC

860156658

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone Sodium Phosphate

Product Details

NDC Product Code
70121-1399
Application Number
ANDA208690
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
December 25, 2023
Code: AI9376Y64PClass: ACTIRQuantity: 10 mg in 1 mL
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACTQuantity: 24.75 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath